Drug intelligence / Profile preview

Laxatan

Development stage
Unknown
Lead developer
Pfizer
Modality
Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Oral
01

Overview

Laxatan is an over-the-counter combination laxative developed by Cassella-Med for the symptomatic treatment of chronic constipation. The formulation consists of macrogol 4000, inulin, and a blend of electrolytes including magnesium citrate, calcium citrate, and potassium chloride. Macrogol 4000 acts as an osmotic laxative by binding water in the intestinal lumen, which increases stool volume and softens consistency to facilitate evacuation. Inulin is included as a prebiotic fiber to promote the growth of beneficial bifidobacteria and lactobacilli in the gut. The electrolyte components are intended to maintain the user's mineral balance, preventing electrolyte shifts often associated with laxative use. It is typically supplied as a granulate for oral solution.

Brand names
LaxatanLaxatan GranulatLaxatan M

Beyond the preview

Go deeper on Laxatan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Laxatan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call